Genetic diagnostic equipmentのメーカーや取扱い企業、製品情報、参考価格、ランキングをまとめています。
イプロスは、 製造業 BtoB における情報を集めた国内最大級の技術データベースサイトです。

Genetic diagnostic equipment - メーカー・企業と業務用製品 | イプロスものづくり

Genetic diagnostic equipmentの製品一覧

1~2 件を表示 / 全 2 件

表示件数

[Research Material] The Global Market for Preimplantation Genetic Diagnosis (PGD)

Global Market for Preimplantation Genetic Diagnosis (PGD): Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis, Fertility Clinics, Academic Medical Centers, Others

This research report (Global Preimplantation Genetic Diagnostics (PGD) Market) investigates and analyzes the current status and outlook for the global market of preimplantation genetic diagnosis (PGD) over the next five years. It includes information on the overview of the global preimplantation genetic diagnosis (PGD) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the preimplantation genetic diagnosis (PGD) market focus on preimplantation genetic screening and preimplantation genetic diagnosis, while the segments by application target infertility treatment clinics, academic medical centers, and others. The regional segments calculate the market size for preimplantation genetic diagnosis (PGD) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the preimplantation genetic diagnosis (PGD) market, product and business overviews, and sales performance.

  • Other services
  • Genetic diagnostic equipment

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録

[Market Report] Global Market for Preimplantation Genetic Diagnosis (PGD)

The global market for preimplantation genetic diagnosis (PGD) is expected to reach new heights by 2031, with an estimated value of 198,603.5 thousand US dollars.

The global preimplantation genetic diagnosis (PGD) market has achieved remarkable growth, providing hope and advanced solutions for individuals and couples aiming to expand their families. The sales revenue in 2022 was approximately $81,520.2 thousand, but it is estimated to soar to $198,603.5 thousand by 2031, with a steady compound annual growth rate (CAGR) of 10.4% projected during the forecast period from 2023 to 2031. The global PGD market is at the forefront of technological innovation in reproductive medicine. With advancements in medicine, the ability to conduct genetic testing on preimplantation embryos has significantly changed family planning. PGD enables individuals and couples to make informed decisions by identifying genetic abnormalities, hereditary diseases, and chromosomal abnormalities that could affect the health of future children. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • Genetic diagnostic equipment

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録